CPL - Chalmers Publication Library
| Utbildning | Forskning | Styrkeområden | Om Chalmers | In English In English Ej inloggad.

Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells

S. C. Coelho ; Sandra Rocha (Institutionen för kemi- och bioteknik, Fysikalisk kemi) ; P. Juzenas ; P. Sampaio ; G. M. Almeida ; F. S. Silva ; M. C. Pereira ; M. A. N. Coelho
Expert Opinion on Drug Delivery (1742-5247). Vol. 10 (2013), 10, p. 1345-1352.
[Artikel, refereegranskad vetenskaplig]

Background: Proteasome inhibition is a current therapeutic strategy used in the treatment of multiple myeloma. Drugs controlling proteasome activity are ideally suited for unidirectional manipulation of cellular pathways such as apoptosis. The first proteasome inhibitor approved in clinics was bortezomib. This drug is currently used in combination with other anticancer agents. Objectives: In this study, the enhancement of bortezomib activity was evaluated using gold nanoparticles coated with poly(ethylene glycol). The uptake mechanism of the gold nanoparticles in pancreatic cell lines, S2-013 and hTERT-HPNE, was assessed by laser scanning confocal microscopy (LSCM). Results: Pancreatic cancer cells internalized the nanoparticles together with the drug in few minutes through the formation of endocytic vesicles. This rapid uptake leads to an increase in the concentration and diffusion of bortezomib in the cytoplasm yielding an increased toxicity on the cells when compared to the drug alone. Conclusion: Gold nanoparticles can be used as effective delivery systems to increasing the permeation and retention of drugs in cancer cells.

Nyckelord: adenocarcinoma, gold nanoparticles, pancreatic cells, proteasome, inhibitor, drug-delivery, cancer-cells, expression, docetaxel, assay

Den här publikationen ingår i följande styrkeområden:

Läs mer om Chalmers styrkeområden  

Denna post skapades 2013-10-28. Senast ändrad 2013-11-20.
CPL Pubid: 185749


Läs direkt!

Länk till annan sajt (kan kräva inloggning)

Institutioner (Chalmers)

Institutionen för kemi- och bioteknik, Fysikalisk kemi (2005-2014)


Nanovetenskap och nanoteknik

Chalmers infrastruktur